학술논문

A randomized phase II study comparing the efficacy and safety of the glyco-optimized anti-EGFR antibody tomuzotuximab against cetuximab in patients with recurrent and/or metastatic squamous cell cancer of the head and neck – the RESGEX study

Document Type

Article

Author

Klinghammer, K.; Fayette, J.; Kawecki, A.; Dietz, A.; Schafhausen, P.; Folprecht, G.; Rottey, S.; Debourdeau, P.; Lavernia, J.; Jacobs, A.; Ahrens-Fath, I.; Dietrich, B.; Baumeister, H.; Zurlo, A.; Ochsenreither, S.; Keilholz, U.

Source

In ESMO Open October 2021 6(5)

Subject

Language

ISSN

2059-7029

Online Access

Full Text (ScienceDirect 종량제) Full Text (Clinical Key) Full Text (ScienceDirect O/A) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송